Public, NASDAQ:CBTE
NASDAQ Capital Market
Commonwealth Biotechnologies Receives Marketplace Rule 4310(c)(14) Notice from NASDAQ
Date: Tue, 25 Nov 2008 19:32:34 GMT
Tags:
Commonwealth Biotechnologies Receives Marketplace Rule 4310(c)(14) Notice from NASDAQ
MarketWatch - Nov 25, 2008
MarketWatch - Nov 25, 2008
RICHMOND, Va., Nov 25, 2008 (BUSINESS WIRE) -- Commonwealth Biotechnologies, Inc. ("CBI") (Nasdaq Capital Market: CBTE), a contract research organization providing outsourced services in the area ...
Commonwealth signs deal for India distribution
Date: Sat, 18 Oct 2008 05:59:54 GMT
Tags:
Commonwealth signs deal for India distribution
IndUS Business Journal - Oct 18, 2008
IndUS Business Journal - Oct 18, 2008
RICHMOND, Va. – Commonwealth Biotechnologies Inc., a US-based firm that offers research and development products and services to the global life sciences industry, has signed a renewable ...
Commonwealth Biotechnologies, Inc. Asian Expansion
Date: Thu, 25 Sep 2008 19:38:31 GMT
Tags:
Commonwealth Biotechnologies, Inc. Asian Expansion
Business Wire (press release) - Sep 25, 2008
Business Wire (press release) - Sep 25, 2008
RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to provide an update regarding its continued expansion into the key Asian markets ...
Commonwealth Biotechnologies Identified as Key Lab in the Amerithrax Investigation
Date: Mon, 22 Sep 2008 14:03:03 GMT
Tags:
Commonwealth Biotechnologies Identified as Key Lab in the Amerithrax Investigation
Business Wire (press release) - Sep 22, 2008
Business Wire (press release) - Sep 22, 2008
RICHMOND, Va.--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (CBI) (Nasdaq: CBTE), a contract research organization providing outsourced services in the area of biotechnology discovery and ...
CBI to Evaluate Zygem's DNA Extraction Technology
Date: Thu, 04 Sep 2008 20:15:16 GMT
Tags:
CBI to Evaluate Zygem's DNA Extraction Technology
GenomeWeb News (subscription) - Sep 4, 2008
GenomeWeb News (subscription) - Sep 4, 2008
By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Zygem said today that Commonwealth Biotechnologies will evaluate how Zygem’s forensicGEM DNA extraction technology works in CBI's forensic ...
COMMONWEALTH BIOTECHNOLOGIES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru (EDGAR Online)
Date: Tue, 25 Nov 2008 20:43:06 Etc/GMT
Tags:
Commonwealth Biotechnologies Receives Marketplace Rule 4310(c)(14) Notice from NASDAQ (Business Wire)
Date: Tue, 25 Nov 2008 19:30:00 Etc/GMT
Tags:
RICHMOND, Va.----Commonwealth Biotechnologies, Inc. , a contract research organization providing outsourced services in the area of biotechnology discovery and development to companies worldwide, today announced that on November 20, 2008, it was notified by the NASDAQ Stock Market that it is no longer in compliance with NASDAQ Marketplace Rule 4310 due to its failure to file its form 10-Q for the period ended September 30, 2008.
COMMONWEALTH BIOTECHNOLOGIES INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Stateme (EDGAR Online)
Date: Thu, 6 Nov 2008 15:11:20 Etc/GMT
Tags:
COMMONWEALTH BIOTECHNOLOGIES INC Files SEC form 8-K, Bankruptcy or Receivership (EDGAR Online)
Date: Tue, 21 Oct 2008 18:45:24 Etc/GMT
Tags:
Commonwealth Biotechnologies, Inc. Asian Expansion (Business Wire)
Date: Thu, 25 Sep 2008 19:37:00 Etc/GMT
Tags:
RICHMOND, Va.----Commonwealth Biotechnologies, Inc. is pleased to provide an update regarding its continued expansion into the key Asian markets of India and China and its positioning for continued growth.